Vivistim Registry for Paired VNS Therapy (GRASP)

Launched by MICROTRANSPONDER INC. · Mar 18, 2022

Keywords

ClinConnect Summary

The Vivistim Registry for Paired VNS Therapy (GRASP) is a clinical trial designed to learn more about how the Vivistim System can help patients who have difficulty using their arms and hands after having a stroke. The study will collect information from patients both before and after they receive the Vivistim System treatment, which involves a small device implanted in the body to help improve arm function. This information will help doctors understand the real-world effects of this therapy on recovery.

To be eligible for this trial, patients must be between the ages of 80 and 35 and have received the Vivistim System specifically for issues related to arm and hand movement after an ischemic stroke, which is caused by a blockage in blood flow to the brain. Patients who are not able to have surgery are excluded from the study. Those who participate can expect to share their experiences and outcomes, and their healthcare providers will be compensated for the time and effort spent on the data collection. This study aims to provide valuable insights into how this treatment can benefit patients post-stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke
• Exclusion Criteria:
• • Not eligible for surgery